The ISCHEMIA Trial — Cardiology Changes Today
The AHA late-breaking trial comparing an invasive vs medical strategy for patients with stable ischemic disease validates Nobel prize-winning medical conservative Bernard Lown, writes John Mandrola, MD.
Related Articles
ACC.25: Symposia on Cardiology
Medscape is pleased to present live symposia in Chicago in March 2025. Each event features expert panelists who will guide interactive discussions and provide information…
Path to less than 500 mg/dl: TG Goals and New Data in Severe Hypertriglyceridemia
Hypertriglyceridemia is causally linked to the development of ASCVD; furthermore, individuals with severe hypertriglyceridemia (sHTG) – triglyceride (TG) lev…
ACC.25: Symposia on Cardiology
ACC.25: Symposia on Cardiology Medscape is pleased to present live symposia in Chicago in March 2025. Each event features expert panelists who will guide interactive…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Saving Hearts: Early Intervention for SCA Prevention
While guideline-directed medical therapy (GDMT) is crucial for managing heart failure and preventing sudden cardiac arrest (SCA), challenges remain in the ea…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…